A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.

A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.

Previously, we have developed a retro-inverso peptide inhibitor (RI-OR2, rGffvlkGr) that blocks the in vitro formation and toxicity of the Aβ oligomers which are thought to be a cause of neurodegeneration and memory loss in Alzheimer's disease. We have now attached a retro-inverted version of t...

Full description

Bibliographic Details
Main Authors:	Vadivel Parthsarathy, Paula L McClean, Christian Hölscher, Mark Taylor, Claire Tinker, Glynn Jones, Oleg Kolosov, Elisa Salvati, Maria Gregori, Massimo Masserini, David Allsop
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23382963/?tool=EBI

Similar Items

Correction: A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease
by: Vadivel Parthsarathy, et al.
Published: (2013-01-01)

Correction: A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease.
by: Vadivel Parthsarathy, et al.
Published: (2013-01-01)

Cholinergic forebrain degeneration in the APPswe/PS1ΔE9 transgenic mouse
by: Sylvia E. Perez, et al.
Published: (2007-10-01)

Recent Applications of Retro-Inverso Peptides
by: Nunzianna Doti, et al.
Published: (2021-08-01)

Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer’s disease
by: Brijesh Kumar Singh, et al.
Published: (2017-10-01)

Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
by: Maria Vincenza Carriero, et al.
Published: (2017-05-01)

Genome-wide analysis of miRNA signature in the APPswe/PS1ΔE9 mouse model of alzheimer's disease.
by: Hongxue Luo, et al.
Published: (2014-01-01)

Suppressed retinal degeneration in aged wild type and APPswe/PS1ΔE9 mice by bone marrow transplantation.
by: Yue Yang, et al.
Published: (2013-01-01)

Evodiamine derivatives improve cognitive abilities in APPswe/PS1ΔE9 transgenic mouse models of Alzheimer's disease
by: Shuo Pang, et al.
Published: (2020-06-01)

A retro-inverso cell-penetrating peptide for siRNA delivery
by: Anaïs Vaissière, et al.
Published: (2017-04-01)

Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model.
by: Vadivel Parthsarathy, et al.
Published: (2013-01-01)

Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice
by: Jun Wang, et al.
Published: (2003-12-01)

Cortical Iron Regulation and Inflammatory Response in Alzheimer’s Disease and APPSWE/PS1ΔE9 Mice: A Histological Perspective
by: Mark D Meadowcroft, et al.
Published: (2015-07-01)

Microglia Express Insulin-Like Growth Factor-1 in the Hippocampus of Aged APPswe/PS1ΔE9 Transgenic Mice
by: Christa Løth Myhre, et al.
Published: (2019-07-01)

Behavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment.
by: Louise Ørum Olesen, et al.
Published: (2016-01-01)

Tailored peptides : the synthesis and conformational behaviour of partially modified retro-inverso peptides
by: Fletcher, Matthew David
Published: (1996)

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
by: Monica Garcia-Alloza, et al.
Published: (2006-12-01)

Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APPSwe/PS1ΔE9 Transgenic Female Mice
by: Madilyn Coles, et al.
Published: (2020-12-01)

Synthesis of the retro-inverso peptide analogues of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP)
by: Franc Tratar, et al.
Published: (2001-08-01)

Curcumin can influence synaptic dysfunction in APPswe/PS1dE9 mice
by: Fang Chen, et al.
Published: (2018-04-01)

Chronic hypoxia induces the in vivo activation of the Wnt/β-catenin signaling pathway and stimulates hippocampal neurogenesis in wild-type and APPswe-PS1deltaE9 transgenic mice
by: Lorena eVarela-Nallar, et al.
Published: (2014-02-01)

Long-Term Caloric Restriction Attenuates β-Amyloid Neuropathology and Is Accompanied by Autophagy in APPswe/PS1delta9 Mice
by: Luisa Müller, et al.
Published: (2021-03-01)

Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice
by: Eva Machová, et al.
Published: (2010-04-01)

Cardiomyocyte contractile dysfunction in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
by: Subat Turdi, et al.
Published: (2009-06-01)

Obesity and Hepatic Steatosis Are Associated with Elevated Serum Amyloid Beta in Metabolically Stressed APPswe/PS1dE9 Mice.
by: Feng-Shiun Shie, et al.
Published: (2015-01-01)

Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy
by: Mengyu Zhang, et al.
Published: (2018-01-01)

Retro-inverso carbohydrate mimetic peptides with annexin1-binding selectivity, are stable in vivo, and target tumor vasculature.
by: Xinyi Chen, et al.
Published: (2013-01-01)

The impact of high fat diet on energy metabolism in APPswe/PS1dE9 transgenic mice
by: Yi-Heng Lee, et al.
Published: (2019)

nAChRs gene expression and neuroinflammation in APPswe/PS1dE9 transgenic mouse
by: D’Angelo Chiara, et al.
Published: (2021-05-01)

Age-related changes in synaptic markers and monocyte subsets link the cognitive decline of APPSwe/PS1 mice.
by: Gaelle eNaert, et al.
Published: (2012-11-01)

Amyloid beta deposition related retinal pigment epithelium cell impairment and subretinal microglia activation in aged APPswePS1 transgenic mice
by: Zhi-Zhang Dong, et al.
Published: (2018-05-01)

Effects of GLP-1 analogue, liraglutide on inflammation, stem cell proliferation, differentiation and cognition in mouse brain
by: Parthsarathy, Vadivel
Published: (2013)

Diverse Protein Profiles in CNS Myeloid Cells and CNS Tissue From Lipopolysaccharide- and Vehicle-Injected APPSWE/PS1ΔE9 Transgenic Mice Implicate Cathepsin Z in Alzheimer’s Disease
by: Camilla Thygesen, et al.
Published: (2018-11-01)

Erratum to “Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice” [Neurobiol. Dis. 14 (2003) 318–327]
by: Jun Wang, et al.
Published: (2004-06-01)

The Protective Effect of Vanadium on Cognitive Impairment and the Neuropathology of Alzheimer’s Disease in APPSwe/PS1dE9 Mice
by: Zhijun He, et al.
Published: (2020-03-01)

Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice.
by: Anna Papazoglou, et al.
Published: (2017-01-01)

Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
by: Miren Ettcheto, et al.
Published: (2017-10-01)

A study investigating the blood-brain barrier penetration, distribution and elimination of retro-inverso peptides as candidate treatments for Alzheimer's disease
by: Michael, Maria
Published: (2017)

Retinal Levels of Amyloid Beta Correlate with Cerebral Levels of Amyloid Beta in Young APPswe/PS1dE9 Transgenic Mice before Onset of Alzheimer’s Disease
by: Xi Mei, et al.
Published: (2020-01-01)

Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: Relationships to β-amyloid deposition and neurotransmitter abnormalities
by: Alena Savonenko, et al.
Published: (2005-04-01)

Cannot write session to /tmp/vufind_sessions/sess_9epfm9nue6g9hqtpchues9hbte